Cyclo Therapeutics Inc

General ticker "CYTH" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $27.0M (TTM average)

Cyclo Therapeutics Inc does not follow the US Stock Market performance with the rate: -35.1%.

Estimated limits based on current volatility of 3.6%: low 0.69$, high 0.74$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.17$, 3.54$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.29$, 3.75$]

Financial Metrics affecting the CYTH estimates:

  • Negative: Non-GAAP EPS, $ of -1.31 <= 0.04
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -40.92 <= 1.81
  • Negative: 0 < Interest expense per share, $ of 0.02
  • Negative: Industry operating cash flow per share per price (median), % of -24.89 <= 2.91

Similar symbols

Short-term CYTH quotes

Long-term CYTH plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.59MM $1.38MM $1.08MM
Operating Expenses $15.88MM $17.00MM $21.13MM
Operating Income $-14.29MM $-15.62MM $-20.05MM
Non-Operating Income $0.00MM $0.17MM $-0.01MM
Interest Expense $0.12MM $0.39MM $0.34MM
R&D Expense $9.15MM $9.00MM $14.18MM
Income(Loss) $-14.29MM $-15.45MM $-20.06MM
Profit(Loss)* $-14.31MM $-15.28MM $-20.06MM
Stockholders Equity $15.67MM $0.73MM $4.76MM
Inventory $0.23MM $0.25MM $0.25MM
Assets $19.52MM $4.22MM $13.25MM
Operating Cash Flow $-15.01MM $-15.11MM $-16.19MM
Capital expenditure $0.02MM $0.02MM $0.00MM
Investing Cash Flow $0.01MM $0.04MM $-0.00MM
Financing Cash Flow $18.76MM $0.01MM $23.89MM
Earnings Per Share** $-2.25 $-1.81 $-1.23

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.